Download PDF
Thromb Haemost 2002; 88(01): 169-170
DOI: 10.1055/s-0037-1613178
Letters to the Editor
Schattauer GmbH

Plasmin/alpha2-antiplasmin Complexes (PAP) in Lung Cancer Patients: Effects of Radiotherapy

Mieczyslaw Uszyński
1   Departments of Propedeutics of Medicine, Poland
,
Ewa Ziólkowska
2   Departments of Regional Centre of Oncology in Bydgoszcz, Poland
,
Ewa Żekanowska
3   Pathophysiology, The Ludwik Rydygier Medical University in Bydgoszcz
,
Waldemar Uszyńki
1   Departments of Propedeutics of Medicine, Poland
› Author Affiliations
Further Information

Publication History

Received 12 July 2001

Accepted after resubmission 11 March 2002

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Taguchi O, Gabbazza EC, Yoshida M, Yamakami T, Kobayashi H, Shima T. High plasma level of plasmin-alpha 2-plasmin inhibitor complex is predictor of poor prognosis in patients with lung cancer. Clin Chim Acta 1996; 244: 69-81.
    CrossrefPubMedGoogle Scholar
  • 2 Seitz R, Rappe N, Kraus M, Immel A, Wolf M, Maasberg M, Egbring R. Pfab R, Havemann K. Activation of coagulation and fibrinolysis in patients with lung cancer; relation to tumour stage and prognosis. Blood Coagul Fibrinolysis 1993; 04: 249-54.
    PubMedGoogle Scholar